Combined synopsis and solicitation
Primary Human Trophoblast Cells
75F40126Q134903
Food and Drug Administration, FDA Office of Acq Grant SVCS. In-Vitro Diagnostic Substance Manufacturing.
Response deadline
August 31, 2026 at 2:00 PM EDT
Closed 16 days ago. Posted August 26, 2026. Scheduled to archive September 15, 2026.
Description
As published on SAM.gov.
See Attached Combined Synopsis/Solicitation 75F40126Q134903
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 26, 2026
Combined synopsis and solicitation
Due August 31, 2026 at 2:00 PM EDT. SAM.gov, notice 8a0e5a3d6eee4a03870e5aa3275f06f3
Points of contact
- Howard Nesmithhoward.nesmith@fda.hhs.gov3017962138
Also open from this buyer
- Electrosurgical unit (ESU)Combined synopsis and solicitationNAICS 339112Maryland75F40126Q00277Closes todaySep 16
- Endoscopy SystemsCombined synopsis and solicitationNAICS 423490Maryland75F40126Q00381Closes todaySep 16
- QELS Dynamic Light Scattering DetectorCombined synopsis and solicitationNAICS 334516Missouri75F40126Q00371Closes todaySep 16
- Human Hindbrain Organoid Functional Assay Services.Combined synopsis and solicitationNAICS 541714RFQ_CDR-2026-135968Closes tomorrowSep 17
- Walk-In Laboratory CoolerSolicitationNAICS 33341575F40126Q00386Closes in 2 daysSep 18